Trump’s decision to pardon or commute the sentences of all the January 6 rioters convicted of crimes was a spur of the moment decision designed to get the issue behind him quickly. “Trump just said: ‘F*ck it: Release ‘em all,’” an advisor recalled.
Trump and his allies are planning to “deconstruct” the administrative state by stripping its power and forcing out tens of thousands of workers. That will put all of our lives at risk.
But elation over the approvals was tempered by concerns the breakthrough treatments may not be accessible to many sickle cell patients, both are very expensive.
It took a while, but the FDA’s proposal on net and drained weight of tuna cans is a good thing; just how much tuna resides in any given can is a mystery.
US regulatory agency makes ‘big change’ to increase the number of participants from under-represented groups in drug testing.
Alzheimer’s might not be primarily a brain disease. Studying beta-amyloids as abnormal proteins that cause Alzheimer’s disease has not translated into a useful drug or therapy. A new theory suggests it’s an autoimmune condition.
FDA guidance for specific sodium reduction goals for the food industry is groundbreaking.
How the Food and Drug Administration messes up approval of new drugs including the new one, aducanumab, that supposedly helps Alzheimer’s disease patients.
Public Citizen, which called for the FDA acting commissioner "to immediately resign or be removed" over the "reckless and inexcusable" drug approval, welcomed her "belated" request.
Spread the word